Vibrios that do not agglutinate in Vibrio cholerae O1 or O139 antiserum are taxonomically included in the species V. cholerae and are referred to as non-O1 V. cholerae.
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Non-O1 V. cholerae organisms have a worldwide distribution and are found ubiquitously in water sources. Sporadic cases result from the ingestion of very large inocula from contaminated water and, occasionally, from food. Non-O1 V. cholerae organisms produce a wide spectrum of diarrheal illness, ranging from severe watery diarrhea indistinguishable from cholera to the milder traveler's diarrhea. Few previous reports have associated non-O1 V. cholerae septicemia with cellulitis. [2] [3] [4] [5] [6] The majority of septicemia occur in immunocompromised patients with hematologic malignancies or cirrhosis. [7] [8] [9] We report a lethal case of non-O1 V. cholerae septicemia with cutaneous bullous lesions that occurred in a patient following hematopoietic stem cell transplantation (HSCT). To our knowledge, this is the first report of non-O1 V. cholerae septicemia with cellulitis in a transplant recipient.
A 54-year-old woman was admitted to The Catholic HSCT Center in June 2002 (day 1233 after HSCT) for a fever with chill, lower back pain and right leg pain of 2 days duration. On past history, she had been diagnosed with acute myeloid leukemia in June 1998, for which she had received induction chemotherapy with idarubicin (12 mg/ m 2 daily intravenous (i.v.) for three consecutive days) and cytarabine (100 mg/m 2 by continuous i.v. infusion for 12 h for seven consecutive days). The first consolidation chemotherapy was performed with amsacrine (100 mg/m 2 daily i.v. for three consecutive days) and etoposide (100 mg/ m 2 daily i.v. for five consecutive days) in September 1998. Peripheral blood stem cell collection could not be undertaken at that time because of an unexplained fever during chemotherapy. The second consolidation chemotherapy with cytarabine (2.0 g/m 2 twice daily i.v. for three consecutive days) and etoposide (100 mg/m 2 daily i.v. for two consecutive days) was performed in November 1998 and peripheral blood stem cells were collected subsequently. The patient then underwent autologous peripheral blood stem cell transplantation (MNC count of 6.18 Â 10 8 / kg, CD34+ cell count of 3.85 Â 10 6 /kg) with conditioning regimen of busulphan (4 mg/kg p.o. in divided doses daily for 3 days), thiotepa (250 mg/m 2 daily i.v. for 2 days) and melphalan (100 mg/m 2 i.v. for one day) in January 1999. Although a toxic hepatopathy and pneumonia developed during the neutropenic period, these subsided after treatment with hepatotonics and empirical antibiotics, including conventional amphotericin B . Ultrasonography showed no evidence of venoocclusive disease. After transplantation, she presented pancytopenia, suggesting engraftment failure (a white blood cell count of less than 3000/mm 3 , a hemoglobin of less than 9.0 g/dl and a platelet count of around 30 000/mm 3 ). A bone marrow examination at day 78 after transplantation showed less than 5% of cellularity of two cell-lines (granuloids and erythroids) and no megakaryocytes and no leukemic blast. At day 90, she was treated with i.v. acyclovir for herpes zoster. Subsequently, no episode of infectious complication was noted. She was not administered any prophylactic antibiotics or any immunosuppressants during post-transplant period. Intermittently, she has received platelet transfusion and conservative care for a lower back pain in an orthopedic surgery clinic because of a year old compression fracture of the lumbar spine.
On presentation, she appeared acutely ill and had a temperature of 36.11C, blood pressure of 90/60 mmHg, a pulse rate of 109 beats/min, and a respiratory rate of 20/ min. A physical examination revealed swelling with tenderness in her right leg, but there was no erythema or bullous skin lesion. She denied recent travel or trauma, seawater exposure or the ingestion of uncooked seafood. Initial laboratory findings were; a white blood cell count of 8800/mm 3 with a left shift, a hemoglobin of 10.0 g/dl and a platelet count of 16 000/mm 3 . Prothrombin time was 84.4% (INR 1.09) and activated partial thromboplastin time 46.6 s (control 31.0 s). Blood urea nitrogen and creatinine were 28.6 and 1.71 mg/dl, respectively. The results of her liver function tests were as follows: aspartate transaminase, 146 IU/dl; alanine transaminase, 132 IU/dl; total bilirubin, 0.76 mg/dl; and albumin, 3.51 g/dl. Electrolytes and an Xray film of the chest were normal. At 4 h after admission, several hemorrhagic bullous skin lesions with erythema developed in her right leg and a fever developed to 38.31C. Two sets of blood and fluid aspiration from an intact bulla were drawn for culture before administering empirical antibiotics, namely, ceftazidime, amikacin and teicoplanin. However, cellulitis with bullous lesions rapidly progressed in the right leg, in size and number. After 18 h, respiratory failure developed and she became deeply confused. Her blood pressure was 75/40 mmHg at 120 beats/min, respiration rate 36/min, and body temperature 37.01C. She received fluid resuscitation with vasopressor therapy, intubation and ventilatory care for the septic condition. However, 24 h after admission, she died despite aggressive cardiopulmonary resuscitation.
After 2 days, all blood and aspiration fluid from the bulla were found to have yielded non-O1 V. cholerae using API 20 E (API System, France). The bacterium was a Gramnegative rod that showed b-hemolysis on blood agar plates and oxidase-positive on MacConkey agar. It grew on thiosulfate-citrate-bile salts-sucrose (TCBS) agar, producing yellow colonies because of sucrose fermentation. It grew in 0% NaCl and was lysine and ornithine decarboxylase positive and arginine dihydrolase negative. The isolate was susceptible in vitro to ampicillin; first-, second-and third-generation cephalosporins; imipenem; gentamicin; trimethoprim-sulfamethoxazole; and ciprofloxacin.
The presence of virulence factors and toxin production was not determined in the isolates. However, previous reports have shown that these are unrelated to the ability of the organism to produce extraintestinal disease. 10 Host factors appear to be more important in the pathogenesis of this disease. In this patient, the viral markers for hepatitis were all negative and there was no previous or current history of liver disease, other than of hepatopathy during HSCT. Like V. cholerae, non-O1 V. cholerae can be found in coastal regions and human infection may occur in association with exposure to seawater or with the ingestion of seafood. The notable feature about this case was the lack of these epidemiologic factors. There was a case report of cellulitis caused by non-O1 V. cholerae acquired from a freshwater inland lake. 4 The organism is more widely distributed than generally appreciated and has the potential to infect in the absence of the usual risk factors. 1, 4 Although bullous lesions frequently occur in patients with V. vulnificus septicemia, this sign has only rarely been reported in non-O1 V. cholerae infection. Early appropriate antibiotic therapy is critical, because the mortality rate of non-O1 V. cholerae septicemia may be as high as 61.5%.
